Vyant Bio Inc (VYNT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2017 | 12-2016 | 12-2015 | 12-2014 | 12-2013 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -20,880 | -15,803 | -20,184 | -16,643 | -12,373 |
| Depreciation Amortization | 3,464 | 2,387 | 1,670 | 1,149 | 1,521 |
| Accounts receivable | -3,583 | -5,850 | -1,662 | -1,657 | -717 |
| Other Working Capital | -5,432 | -5,645 | 934 | -1,219 | -1,817 |
| Other Operating Activity | 12,867 | 7,060 | 5,643 | 6,032 | 5,311 |
| Operating Cash Flow | $-13,564 | $-17,851 | $-13,599 | $-12,338 | $-8,075 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -1,284 | -490 | -1,008 | -1,374 | -257 |
| Net Acquisitions | -1,091 | N/A | N/A | -2,869 | N/A |
| Purchase Of Investment | -200 | N/A | N/A | -1,000 | -1,000 |
| Purchase Sale Intangibles | -126 | -119 | -137 | -130 | -92 |
| Other Investing Activity | -126 | -119 | -1,632 | -6,130 | -142 |
| Investing Cash Flow | $-2,701 | $-609 | $-2,640 | $-11,373 | $-1,399 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 10,137 | N/A | N/A | N/A | N/A |
| Debt Repayment | -4,897 | -1,459 | -83 | -452 | -3,597 |
| Common Stock Issued | 11,385 | 9,962 | 10,377 | 257 | 61,711 |
| Other Financing Activity | -287 | 0 | -150 | 0 | 0 |
| Financing Cash Flow | $16,338 | $8,503 | $10,144 | $-195 | $58,114 |
| Exchange Rate Effect | 16 | N/A | N/A | N/A | N/A |
| Beginning Cash Position | 9,802 | 19,459 | 25,554 | 49,460 | 820 |
| End Cash Position | 9,891 | 9,502 | 19,459 | 25,554 | 49,460 |
| Net Cash Flow | $89 | $-9,957 | $-6,095 | $-23,906 | $48,640 |
| Free Cash Flow | |||||
| Operating Cash Flow | -13,564 | -17,851 | -13,599 | -12,338 | -8,075 |
| Capital Expenditure | -1,284 | -490 | -1,008 | -1,374 | -257 |
| Free Cash Flow | -14,848 | -18,341 | -14,607 | -13,712 | -8,332 |